needed effects
atazanavir
active ingredient
reyataz
unwanted side effects
medical attention
atazanavir side effects
medical attention
body
medicine
side effects
health care professional
side effects
following side effects
common side effects
therapy-naive patients during clinical trials
nausea
jaundice/scleral icterus
rash
common side effects
therapy-experienced patients during clinical trials
jaundice/scleral icterus
myalgia
elevated total bilirubin
least times
upper limit of normal
uln
alt
least times uln
ast
least times uln
patients
most patients
drug
asymptomatic elevations in indirect
bilirubin
inhibition of udp-glucuronosyl transferase
hyperbilirubinemia
discontinuation of this drug
bilirubin
elevated total bilirubin
elevated alt
jaundice
elevated ast
jaundice/scleral icterusuncommon
hepatitisrare
hepatosplenomegalyfrequency
hepatomegaly
liver damage
acute hepatic cytolysis
biliary lithiasis
choledocholithiasispostmarketing reports
hepatic function abnormalities
cholelithiasis
cholecystitis
cholestasis
elevated total cholesterol
least mg/dl
triglycerides
least mg/dl
glucose
least mg/dl
patients
elevated total cholesterol
elevated triglycerides
elevated glucoseuncommon
anorexia
appetite
weight
weight gainrare
ketoacidosisfrequency
elevated ldl cholesterol
elevated hdl cholesterol
hyperkalemia
lactic acidosis
hyperlactatemia
redistribution/accumulation of body fat
including
central obesity
dorsocervical fat enlargement
peripheral wasting
facial wasting
breast enlargement
cushingoid appearance
hypertriglyceridemia
hypercholesterolemia
insulin resistancepostmarketing reports
new onset diabetes mellitus
exacerbation
preexisting diabetes mellitus
hyperglycemia
rash
lipodystrophyuncommon
alopecia
pruritus
urticariarare
vesiculobullous rash
eczemafrequency
photosensitivitypostmarketing reports
maculopapular rash
erythema multiforme
toxic skin eruptions
drug rash with eosinophilia
systemic symptoms
dress
syndrome
angioedema
stevens-johnson syndrome
elevated amylase
least times uln
lipase
least times uln
patients
nausea
elevated amylase
elevated lipase
abdominal pain
diarrhea
vomiting
dyspepsiauncommon
dry mouth
flatulence
gastritis
pancreatitis
abdominal distension
aphthous stomatitisfrequency
acholia
colitis
constipation
dental pain
esophageal ulcer
gastrointestinal disorder
peptic ulcer
sialolithiasis/parotid gland lithiasis
headache
peripheral neurological symptoms
dizzinessuncommon
syncope
peripheral neuropathy
amnesia
somnolence
dysgeusiafrequency
paresthesias
elevated creatine kinase
pain
myalgia
arthralgiauncommon
muscle atrophyrare
myopathyfrequency
bone pain
extremity pain
myasthenia
osteonecrosis
elevated creatine kinase
least times uln
patients
decreased neutrophils
hemoglobin
plateletsrare
spontaneous bleeding in hemophiliacs
decreased neutrophils
cells/mm
hemoglobin
g/dl
platelets
cells/mm
patients
fever/pyrexia
pain
fatigue
asthenia
lipodystrophy syndromeuncommon
chest pain
malaise
gait disturbancesrare
edemafrequency
burning sensation
dysplasia
facial atrophy
generalized edema
heat sensitivity
infection
overdose
pallor
peripheral edema
substernal chest pain
sweating
semicircular canal lithiasis
depression
insomniauncommon
anxiety
disorientation
disorder
abnormal dream
scleral icterus/ocular icterus
increased coughuncommon
dyspnea
healthy volunteers
patients
abnormalities in av conduction
first-degree av block
year-old hiv-infected woman with congestive heart failure
ejection fraction
started lamivudine
zidovudine
atazanavir
active ingredient
reyataz
month
patient
syncope
nausea
begun days
month after therapy initiation
patient
progressive shortness of breath
ecg
qtc interval prolongation of min
starting
starting antiretroviral therapy
ecg
qtc interval of min for the patient
patient
continuous ventricular tachycardia
sinus bradycardia
qt interval prolongation
patient
torsades de pointes
further defibrillation
treatment
heart rate
qt interval
patient
antiretroviral therapy
hospitalization
concerns
regarding qt prolongation
patient
qtc interval
min
additional ventricular tachyarrhythmias
patient
lamivudine
zidovudine
atazanavir
days
ecg
qtc interval prolongation
min
atazanavir
cause of the prolonged qt interval
torsades de pointes
patient
qt interval
normal following discontinuation
antiretroviral therapy
hypertensionrare
palpitation
vasodilatationfrequency
prolongation of the pr interval
abnormalities in atrioventricular
av
conduction
first-degree av block
prolonged qt interval
ventricular tachycardia
qrs interval
heart arrest
heart block
myocarditispostmarketing reports
second-degree av block
third-degree av block
bundle branch block
qtc prolongation
torsades de pointes
interstitial nephritisrare
acute interstitial nephritis
renal colic
reversible acute renal failure
urolithiasis
kidney painpostmarketing reports
nephrolithiasis
hydronephrosis
renal insufficiency
analysis of a ureteral stone
atazanavir metabolite
calcium phosphate
carbonate apatite
stone
metabolites
apatite
atazanavir crystals
analysis of renal calculi from additional patients
concentrations of atazanavir
hypersensitivityfrequency
allergic reaction
hematuria
frequency of micturition/pollakiuria
proteinuria
gynecomastiafrequency
decreased male fertility
frequency
immune reconstitution syndrome
autoimmune disorders in the setting of immune reconstitution
graves
disease
polymyositis
guillain-barre syndrome
side effects of reyataz
fda
healthcare professional for medical advice
stomach discomfort
fullness
pain
bloating
blood in the urine
blurred vision
chest pain
discomfort
chills
clay-colored stools
constipation
dark-colored urine
decreased appetite
diarrhea
dizziness or lightheadedness
dry mouth
fainting
fast heartbeat
fast, shallow breathing
fever
flushed, dry skin
fruit-like breath odor
stomach pain
general feeling of discomfort
headache
hives
itching
skin rash
increased hunger
increased thirst
increased urination
indigestion
irregular heartbeat
loss of appetite
loss of consciousness
muscle pain
cramping
nausea
pain in the groin
genitals
pain in the stomach
side
abdomen
radiating
back
recurrent fever
severe nausea
vomiting
sharp back pain
ribs
sleepiness
irregular heartbeat
stomachache
sweating
swelling
tightness in the chest
trouble with breathing
unexplained weight loss
unpleasant breath odor
unusual tiredness
weakness
vomiting
vomiting of blood
yellow eyes
skin
back pain
cough, increased
discouragement
extra body fat
feeling
irritability
loss of interest
pleasure
trouble concentrating
trouble sleeping
burning
numbness
tingling
painful sensations
difficulty with moving
muscle stiffness
pain
pain in the joints
unsteadiness or awkwardness
weakness in the arms
hands
legs
feet
hair loss
thinning of the hair
rash with flat lesions
small raised lesions on the skin